Select Publications
Journal articles
, 2010, 'Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis', Lancet, 375, pp. 1875 - 1884, http://dx.doi.org/10.1016/S0140-6736(10)60656-3
Conference Papers
, 2025, 'Incidence of CKD in Australian Primary Care: Analysis of a National Primary Care Dataset', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025
, 2025, 'Sex-Related Differences in CKD Monitoring and Cardiovascular Risk Management in Australian Primary Care: A Retrospective Cohort Study', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025
, 2025, 'Variability in eGFR and Adverse Kidney Outcomes in Routine Clinical Practice', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, TX, Houston, presented at Kidney Week, TX, Houston, 05 November 2025 - 09 November 2025
, 2025, 'Age-Standardised Prevalence of Diabetes, Chronic Kidney Disease and Cardiovascular Disease in Melbourne's West', in NEPHROLOGY, WILEY
, 2023, 'Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, PA, Philadelphia, pp. 367 - 367, presented at Kidney Week, PA, Philadelphia, 01 November 2023 - 05 November 2023
, 2023, 'ADHERENCE AND LONG-TERM TRENDS IN UPTAKE OF CARDIOPROTECTIVE MEDICATION FOLLOWING AN ACUTE MYOCARDIAL INFARCTION AMONG PEOPLE WITH DIABETES AND CKD - A PROSPECTIVE POPULATION-BASED STUDY', in NEPHROLOGY, WILEY, pp. 28 - 28
, 2023, 'LONG-TERM SAFETY OF HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in NEPHROLOGY, WILEY, pp. 12 - 12
, 2023, 'Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 367 - 367
, 2023, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 373 - 373
, 2022, 'Lower Glomerular Filtration Rate and Higher Albuminuria Are Associated With Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 297 - 298
, 2021, 'CLINICAL OUTCOMES AND PATIENT CHARACTERISTICS ACCORDING TO THE COMBINATION OF TEN-YEAR RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND SYSTOLIC BLOOD PRESSURE', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, pp. E239 - E240, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000672599903108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Comparative effectiveness and safety of direct oral anticoagulants in non-valvular atrial fibrillation: a multi-center observational cohort study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 409 - 410, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785603068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'ASSESSING BASELINE MEDICATION USE IN CHRONIC KIDNEY DISEASE: AN ANALYSIS OF THE SHARP-ER STUDY', in NEPHROLOGY, WILEY, pp. 25 - 25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'CAUSE OF DEATH VARIES ACROSS AUSTRALIA, NEW ZEALAND AND MALAYSIA IN THOSE ON RENAL REPLACEMENT THERAPY - RESULTS FROM THE STUDY OF HEART AND RENAL PROTECTION-EXTENDED REVIEW (SHARP-ER)', in NEPHROLOGY, WILEY, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Acute Increase in Creatinine after Starting ACE Inhibitor and Vascular Events and Premature Death in Patients with Type 2 Diabetes-The ADVANCE Trial', in DIABETES, AMER DIABETES ASSOC, FL, Orlando, presented at 78th Scientific Sessions of the American-Diabetes-Association, FL, Orlando, 22 June 2018 - 26 June 2018, http://dx.doi.org/10.2337/db18-1483-P
, 2015, 'EFFECTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS', in Journal of the American College of Cardiology, Elsevier, pp. a1448, http://dx.doi.org/10.1016/s0735-1097(15)61448-6
Conference Posters
, 2022, 'POS-254 CLINICAL AND SAFETY OUTCOMES WITH APIXABAN VERSUS WARFARIN BY EGFR IN ADULTS WITH ATRIAL FIBRILLATION', Vol. 7, pp. S111 - S112, http://dx.doi.org/10.1016/j.ekir.2022.01.273
Conference Presentations
, 2024, 'Trends in the use of sodium-glucose cotransporter 2 inhibitors following hospitalisation with heart failure, New South Wales, Australia', presented at 13th Health Services Research Conference, Brisbane, Australia, 05 December 2024 - 06 December 2024
, 2024, 'Trends in the use of sodium-glucose cotransporter 2 inhibitors following hospitalisation with heart failure, New South Wales, Australia', presented at 16th Asian Conference on Pharmacoepidemiology, Tokyo, Japan, 12 October 2024 - 14 October 2024
Conference Abstracts
, 2025, 'Baseline analysis of the patterns of CKD care in an implementation trial using future health today in primary care', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, Vol. 40, http://dx.doi.org/10.1093/ndt/gfaf116.0583
, 2025, 'Prevalence of Cardiova scular-Kidney-Metabolic Multimorbidity in Australian Primary Care: Estimates From A National General Practice Dataset', in NEPHROLOGY, WILEY, Vol. 30
, 2025, 'Sex-Related Differences in CKD Monitoring and Cardiovascular Risk Management in Australian Primary Care: A Retrospective Cohort Study', in Journal of the American Society of Nephrology, Wolters Kluwer, Vol. 36, pp. 10.1681/asn.2025qfjjvkhp, http://dx.doi.org/10.1681/asn.2025qfjjvkhp
, 2024, 'ALBUMINURIA, KIDNEY FUNCTION AND HEART FAILURE IN TYPE 2 DIABETES: A SECONDARY ANALYSIS FROM THE CANVAS PROGRAM AND CREDENCE TRIAL', in NEPHROLOGY, WILEY, Vol. 29, pp. 75 - 75
, 2024, 'QUALITY OF CHRONIC KIDNEY DISEASE CARE IN AUSTRALIAN PRIMARY CARE: ANALYSIS OF A NATIONAL GENERAL PRACTICE DATASET', in NEPHROLOGY, WILEY, Vol. 29, pp. 13 - 13
, 2021, 'Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 219 - 220, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300446&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'PLASMA FATTY ACIDS AND THE RISK OF VASCULAR AND MORTALITY OUTCOMES IN INDIVIDUALS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE STUDY', in JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, pp. E45 - E45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000672599900120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE', in NEPHROLOGY, WILEY, Vol. 25, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'SUN-119 COMPARING SURVIVAL IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACROSS THREE COUNTRIES - RESULTS FROM THE STUDY OF HEART AND RENAL PROTECTION-EXTENDED REVIEW (SHARP-ER)', in Kidney International Reports, Elsevier, Vol. 5, pp. s250, http://dx.doi.org/10.1016/j.ekir.2020.02.646
, 2019, '1129-P: Association between the Intensity of Diabetes Therapy, Achieved HbA1c, and Persistence', in Diabetes, American Diabetes Association, CA, San Francisco, Vol. 68, presented at 79th Scientific Sessions of the American-Diabetes-Association (ADA), CA, San Francisco, 07 June 2019 - 11 June 2019, http://dx.doi.org/10.2337/db19-1129-p
, 2019, '1130-P: Temporal Trends in Pharmacotherapy for Diabetes', in Diabetes, American Diabetes Association, CA, San Francisco, Vol. 68, presented at 79th Scientific Sessions of the American-Diabetes-Association (ADA), CA, San Francisco, 07 June 2019 - 11 June 2019, http://dx.doi.org/10.2337/db19-1130-p
, 2018, 'ASSESSING THE RISK AND SEVERITY OF HOSPITALISATIONS ACCORDING TO LEVEL OF KIDNEY FUNCTION: AN EXTEND45 ANALYSIS', in NEPHROLOGY, WILEY, Vol. 23, pp. 51 - 51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'INFECTION-RELATED HOSPITALISATIONS ACROSS DIFFERENT LEVELS OF KIDNEY FUNCTION: DATA FROM THE EXTEND45 STUDY', in NEPHROLOGY, WILEY, Vol. 23, pp. 40 - 40
, 2018, 'KIDNEY FUNCTION, GLUCOSE-LOWERING TREATMENT AND HBA1C LEVELS IN PEOPLE WITH PREVALENT DIABETES: A POPULATION-BASED COHORT STUDY (EXTEND45)', in NEPHROLOGY, WILEY, Vol. 23, pp. 38 - 38
, 2018, 'PREDICTORS OF CHRONIC KIDNEY DISEASE IN THE EXTEND45 STUDY: A NSW POPULATION-BASED STUDY', in NEPHROLOGY, WILEY, Vol. 23, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'SOCIOECONOMIC, DEMOGRAPHIC AND CLINICAL ASSOCIATIONS OF CHRONIC KIDNEY DISEASE IN DIABETES IN A POPULATION-BASED NSW COHORT: RESULTS FROM THE EXTEND45 STUDY', in NEPHROLOGY, WILEY, Vol. 23, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'THE MAKE-UP OF CARDIOVASCULAR DISEASE AS KIDNEY FUNCTION DECLINES: RESULTS FROM A POPULATION-BASED COHORT STUDY (EXTEND45)', in NEPHROLOGY, WILEY, Vol. 23, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'Intensive glucose lowering and end stage kidney disease: new data from the ADVANCE trial', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, Vol. 54, pp. S23 - S23, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 12 September 2011 - 16 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307671300040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Reports
, 2017, Direct oral anticoagulants and venous thromboembolism
Preprints
, 2025, The association between low-grade proteinuria and adverse kidney outcomes in IgA nephropathy: A systematic review and meta-analysis, http://dx.doi.org/10.1101/2025.08.12.25333541
, 2024, Effects of iron on cardiovascular, kidney and safety outcomes in patients with chronic kidney disease: a systematic review and meta-analysis, http://dx.doi.org/10.1101/2024.03.28.24305010
, 2023, Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care, http://dx.doi.org/10.1101/2023.06.26.23291881
, EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study (Preprint), http://dx.doi.org/10.2196/preprints.15646
, Identifying and integrating consumer-prioritised topics and outcomes in clinical practice guidelines on managing kidney stones, http://dx.doi.org/10.21203/rs.3.rs-4727048/v1
, The GLP-1 RA boom: Trends in publicly subsidised and private access in Australia, 2020-2025, http://dx.doi.org/10.1101/2025.10.30.25339120
, The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset, http://dx.doi.org/10.1101/2023.06.18.23290762